PowderJect - Revision history

Matthew Pringle: /* Vaccine withdrawal */

2016-07-17T17:14:57Z

Vaccine withdrawal

Matthew Pringle: Controversy

2016-07-17T17:07:28Z

Controversy

Matthew Pringle: categories added

2016-07-13T14:32:02Z

categories added

Matthew Pringle: Affiliations - SMC funding info added

2013-10-25T12:01:49Z

Affiliations - SMC funding info added

Melissa Jones at 01:27, 19 August 2013

2013-08-19T01:27:10Z

Melissa Jones: fixed ref

2013-08-19T01:26:53Z

fixed ref

David at 18:16, 18 August 2013

2013-08-18T18:16:31Z

David: /* Resources */

2013-08-18T11:07:16Z

Resources

David at 10:43, 18 August 2013

2013-08-18T10:43:33Z

David at 10:38, 18 August 2013

2013-08-18T10:38:13Z

@@ Line 20: / Line 20: @@
 ===Vaccine withdrawal===
 In 2002 PowderJect recalled its supply of BCG vaccine throughout the UK and Ireland after routine tests revealed that some batches were not up to specification.<ref>Amy Frizell, [http://www.independent.co.uk/news/business/news/powderject-withdraws-anti-tuberculosis-vaccine-172827.html 'Powderject withdraws anti-tuberculosis vaccine'], ''The Independent'', 9 August 2002.</ref>
 ==People==

← Older revision		Revision as of 17:07, 17 July 2016
Line 6:		Line 6:
	:Mr Drayson, the chief executive, who pumped £250,000 into PowderJect when he joined 10 years ago, will pocket almost £43m from his 8% holding. His father-in-law, [[Brian Bellhouse]], the brains behind the company's much-hyped needle-free injection technology, will pick up £19.5m for his 3.6% stake, while the two men's family trusts will receive £41m of cash.<ref name="Gibbs"/>		:Mr Drayson, the chief executive, who pumped £250,000 into PowderJect when he joined 10 years ago, will pocket almost £43m from his 8% holding. His father-in-law, [[Brian Bellhouse]], the brains behind the company's much-hyped needle-free injection technology, will pick up £19.5m for his 3.6% stake, while the two men's family trusts will receive £41m of cash.<ref name="Gibbs"/>

		+	==Controversy==
		+	===Papers detail Labour donor's vaccine deal===
		+	The Guardian reported:
		+
		+	:[[Paul Drayson]], who has since become a life peer, made an estimated £20m for his company Powderject from the government's hasty purchase of smallpox vaccine in the wake of the terrorist attacks on September 11 2001.
		+
		+	:The documents show how Lord Drayson gained a crucial early advantage in winning the contract by securing a deal with the only manufacturer able to supply the vaccine quickly.
		+
		+	:The Whitehall files have been released because the health secretary, John Reid, has backed down after a clash with the parliamentary ombudsman, Ann Abraham. She called his refusal to follow her recommendation to publish the documents "a matter of great concern".
		+
		+	:The vaccine contract was mired in accusations of sleaze because Lord Drayson gave a second £50,000 donation to the Labour party while the government was deciding who should be handed the contract.<ref>David Leigh and Rob Evans, [https://www.theguardian.com/uk/2004/jun/29/politics.freedomofinformation 'Papers detail Labour donor's vaccine deal'], ''The Guardian'', 29 June 2004.</ref>
		+
		+	===Vaccine withdrawal===
		+	In 2002 PowderJect recalled its supply of BCG vaccine throughout the UK and Ireland after routine tests revealed that some batches were not up to specification.<ref>Amy Frizell, [http://www.independent.co.uk/news/business/news/powderject-withdraws-anti-tuberculosis-vaccine-172827.html 'Powderject withdraws anti-tuberculosis vaccine'], ''The Independent'', 9 August 2002.</ref>

	==People==		==People==

← Older revision		Revision as of 14:32, 13 July 2016
Line 20:		Line 20:
	==Notes==		==Notes==
	<references/>		<references/>
		+
		+	[[Category:Pharmaceutical Industry‏‎]][[Category:Science Media Centre]]

@@ Line 9: / Line 9: @@
 ==People==
 *[[Paul Drayson]]
 ==Resources==

← Older revision		Revision as of 01:27, 19 August 2013
Line 1:		Line 1:
−	[[PowderJect]], was 'a vaccine, drug and diagnostics delivery company specialising in the needle-free, pain-free injection of drugs, biophamaceuticals, conventional and DNA Vaccines and diagnostics in dry powder form.'<ref name="Isis">Isis [http://www.isis-innovation.com/spinout/powderject.html PowderJect Pharmaceuticals Plc - part of Novartis AG], accessed 18 August 2013</ref> It was 'originally spun out' from the [[University of Oxford]] in 1993 with the aid of [[Isis Innovation]].<ref name="Isis"/> In 2003, PowderJect was acquired [[Chiron Corporation]] for $800m. In April 2006 Chiron was bought out by [[Novartis Vaccines and Diagnostics]] part of [[Novartis]].</ref>Thomson Reuters [http://cws.huginonline.com/N/134323/PR/200604/1045686_5_2.html Novartis acquisition of Chiron approved by Chiron shareholders], 19/04/2006, 2006, 6.28 PM CET </ref>	+	[[PowderJect]], was 'a vaccine, drug and diagnostics delivery company specialising in the needle-free, pain-free injection of drugs, biophamaceuticals, conventional and DNA Vaccines and diagnostics in dry powder form.'<ref name="Isis">Isis [http://www.isis-innovation.com/spinout/powderject.html PowderJect Pharmaceuticals Plc - part of Novartis AG], accessed 18 August 2013</ref> It was 'originally spun out' from the [[University of Oxford]] in 1993 with the aid of [[Isis Innovation]].<ref name="Isis"/> In 2003, PowderJect was acquired [[Chiron Corporation]] for $800m. In April 2006 Chiron was bought out by [[Novartis Vaccines and Diagnostics]] part of [[Novartis]].<ref>Thomson Reuters [http://cws.huginonline.com/N/134323/PR/200604/1045686_5_2.html Novartis acquisition of Chiron approved by Chiron shareholders], 19/04/2006, 2006, 6.28 PM CET </ref>
	In 2002 PowderJect, 'was caught up in controversy... after winning a £32m smallpox vaccine contract from the government'.<ref name="Gibbs">Geoffrey Gibbs [http://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1 £43m windfall for PowderJect chief] ''The Guardian'', Tuesday 20 May 2003 02.34 BST</ref>		In 2002 PowderJect, 'was caught up in controversy... after winning a £32m smallpox vaccine contract from the government'.<ref name="Gibbs">Geoffrey Gibbs [http://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1 £43m windfall for PowderJect chief] ''The Guardian'', Tuesday 20 May 2003 02.34 BST</ref>

@@ Line 1: / Line 1: @@
-[[PowderJect]], was 'a vaccine, drug and diagnostics delivery company specialising in the needle-free, pain-free injection of drugs, biophamaceuticals, conventional and DNA Vaccines and diagnostics in dry powder form.'<ref name="Isis">Isis [http://www.isis-innovation.com/spinout/powderject.html PowderJect Pharmaceuticals Plc - part of Novartis AG], accessed 18 August 2013</ref> It was 'originally spun out' from the [[University of Oxford]] in 1993 with the aid of [[Isis Innovation]].<ref name="Isis"/> In 2003, PowderJect was acquired [[Chiron Corporation]] for $800m. In April 2006 Chiron was bought out by [[Novartis Vaccines and Diagnostics]] part of [[Novartis]].<ref name="Isis"/>Thomson Reuters [http://cws.huginonline.com/N/134323/PR/200604/1045686_5_2.html  Novartis acquisition of Chiron approved by Chiron shareholders], 19/04/2006, 2006, 6.28 PM CET </ref>
+[[PowderJect]], was 'a vaccine, drug and diagnostics delivery company specialising in the needle-free, pain-free injection of drugs, biophamaceuticals, conventional and DNA Vaccines and diagnostics in dry powder form.'<ref name="Isis">Isis [http://www.isis-innovation.com/spinout/powderject.html PowderJect Pharmaceuticals Plc - part of Novartis AG], accessed 18 August 2013</ref> It was 'originally spun out' from the [[University of Oxford]] in 1993 with the aid of [[Isis Innovation]].<ref name="Isis"/> In 2003, PowderJect was acquired [[Chiron Corporation]] for $800m. In April 2006 Chiron was bought out by [[Novartis Vaccines and Diagnostics]] part of [[Novartis]].</ref>Thomson Reuters [http://cws.huginonline.com/N/134323/PR/200604/1045686_5_2.html  Novartis acquisition of Chiron approved by Chiron shareholders], 19/04/2006, 2006, 6.28 PM CET </ref>
 In 2002 PowderJect, 'was caught up in controversy... after winning a £32m smallpox vaccine contract from the government'.<ref name="Gibbs">Geoffrey Gibbs [http://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1 £43m windfall for PowderJect chief] ''The Guardian'', Tuesday 20 May 2003 02.34 BST</ref>
@@ Line 5: / Line 5: @@
 :Mr Drayson, the chief executive, who pumped £250,000 into PowderJect when he joined 10 years ago, will pocket almost £43m from his 8% holding. His father-in-law, [[Brian Bellhouse]], the brains behind the company's much-hyped needle-free injection technology, will pick up £19.5m for his 3.6% stake, while the two men's family trusts will receive £41m of cash.<ref name="Gibbs"/>

← Older revision		Revision as of 18:16, 18 August 2013
Line 1:		Line 1:
−	[[PowderJect]], was 'a vaccine, drug and diagnostics delivery company specialising in the needle-free, pain-free injection of drugs, biophamaceuticals, conventional and DNA Vaccines and diagnostics in dry powder form.'<ref name="Isis">Isis [http://www.isis-innovation.com/spinout/powderject.html PowderJect Pharmaceuticals Plc - part of Novartis AG], accessed 18 August 2013</ref> It was 'originally spun out' from the [[University of Oxford]] in 1993 with the aid of [[Isis Innovation]].<ref name="Isis"/> In 2003, PowderJect was acquired [[Chiron Corporation]] for $800m. Chiron was ~~subsequently~~ bought out by [[Novartis Vaccines and Diagnostics]] part of [[Novartis]].<ref name="Isis"/>	+	[[PowderJect]], was 'a vaccine, drug and diagnostics delivery company specialising in the needle-free, pain-free injection of drugs, biophamaceuticals, conventional and DNA Vaccines and diagnostics in dry powder form.'<ref name="Isis">Isis [http://www.isis-innovation.com/spinout/powderject.html PowderJect Pharmaceuticals Plc - part of Novartis AG], accessed 18 August 2013</ref> It was 'originally spun out' from the [[University of Oxford]] in 1993 with the aid of [[Isis Innovation]].<ref name="Isis"/> In 2003, PowderJect was acquired [[Chiron Corporation]] for $800m. In April 2006 Chiron was bought out by [[Novartis Vaccines and Diagnostics]] part of [[Novartis]].<ref name="Isis"/>Thomson Reuters [http://cws.huginonline.com/N/134323/PR/200604/1045686_5_2.html Novartis acquisition of Chiron approved by Chiron shareholders], 19/04/2006, 2006, 6.28 PM CET </ref>
−
	In 2002 PowderJect, 'was caught up in controversy... after winning a £32m smallpox vaccine contract from the government'.<ref name="Gibbs">Geoffrey Gibbs [http://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1 £43m windfall for PowderJect chief] ''The Guardian'', Tuesday 20 May 2003 02.34 BST</ref>		In 2002 PowderJect, 'was caught up in controversy... after winning a £32m smallpox vaccine contract from the government'.<ref name="Gibbs">Geoffrey Gibbs [http://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1 £43m windfall for PowderJect chief] ''The Guardian'', Tuesday 20 May 2003 02.34 BST</ref>

@@ Line 14: / Line 14: @@
 ==Resources==
 * Steve Doughty [http://www.dailymail.co.uk/news/article-1193282/Lord-Moneyjabs-How-Drayson-fattened-drug-firm-taxpayer--80m-selling-Americans.html Lord Moneyjabs: How Drayson fattened up his drug firm on the taxpayer - then made £80m selling it to Americans] ''[[Daily Mail]]'', UPDATED: 01:18, 16 June 2009.
 ==Notes==
 <references/>

@@ Line 1: / Line 1: @@
 [[PowderJect]], was 'a vaccine, drug and diagnostics delivery company specialising in the needle-free, pain-free injection of drugs, biophamaceuticals, conventional and DNA Vaccines and diagnostics in dry powder form.'<ref name="Isis">Isis [http://www.isis-innovation.com/spinout/powderject.html PowderJect Pharmaceuticals Plc - part of Novartis AG], accessed 18 August 2013</ref> It was 'originally spun out' from the [[University of Oxford]] in 1993 with the aid of [[Isis Innovation]].<ref name="Isis"/> In 2003, PowderJect was acquired [[Chiron Corporation]] for $800m. Chiron was subsequently bought out by [[Novartis Vaccines and Diagnostics]] part of [[Novartis]].<ref name="Isis"/>
-In 2002 PowderJect, 'was caught up in controversy... after winning a £32m smallpox vaccine contract from the government'.<ref name="Gibbs">Geoffrey Gibbs [http://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1£43m windfall for PowderJect chief] ''The Guardian'', Tuesday 20 May 2003 02.34 BST</ref>
+In 2002 PowderJect, 'was caught up in controversy... after winning a £32m smallpox vaccine contract from the government'.<ref name="Gibbs">Geoffrey Gibbs [http://www.theguardian.com/business/2003/may/20/executivesalaries.executivepay1 £43m windfall for PowderJect chief] ''The Guardian'', Tuesday 20 May 2003 02.34 BST</ref>
 In 2003 PowderJect, 'headed by Labour donor [[Paul Drayson]]', was subject to a £542m takeover bid from US pharmaceuticals group Chiron - 'yielding a £100m windfall for Mr Drayson, his father-in-law and their families.'<ref name="Gibbs"/>